AKUMS · Healthcare · Drug Manufacturers - Specialty & Generic
Composite scorecard: 44/100 — Quality 47 · Valuation 17 · Growth 72 · Momentum 36
| Share price | ₹676.55 |
| Market cap | ₹7,479 Cr |
| P/E ratio | 23.4 |
| P/B ratio | 2.4 |
| ROE | 18.2% |
| ROCE | 11.7% |
| Book value | ₹205.37 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹4,359 Cr | ₹256 Cr | 12.0% |
| 2025 | ₹4,118 Cr | ₹344 Cr | 11.0% |
| 2024 | ₹4,178 Cr | ₹1 Cr | 3.0% |
| 2023 | ₹3,655 Cr | ₹98 Cr | 8.0% |
| 2022 | ₹3,672 Cr | ₹-251 Cr | -2.0% |
Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, herbals, toiletries, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offers branded formulations on various dosage forms, including tablets, capsules, injectables, opthalmics, and soft gelatin capsules for therapeutic areas, such as gynaecology, cardiol